LAVA Therapeutics NV () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1287334,
    "name": "LAVA Therapeutics NV",
    "stock_name": "LAVA Therapeutics NV",
    "full_name": "LAVA Therapeutics NV",
    "name_url": "stocks-analysis/lava-therapeutics-nv",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.74",
    "chg": -0.07,
    "chgp": "-3.87%",
    "dir": -1,
    "prev_price": "1.81",
    "mcapval": "40.77",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "NL0015000AG6",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "571.04 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2025",
    "traded_date_str": "2025 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lava-therapeutics-nv-1287334-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is LAVA Therapeutics NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lava-therapeutics-nv-technically-bullish-or-bearish-3547851",
        "imagepath": "",
        "date": "2025-09-20 20:04:27",
        "description": "As of 24 July 2025, the technical trend for LAVA Therapeutics NV has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating positive momentum. The daily moving averages also reflect a mildly bullish stance. However, the monthly Bollinger Bands are bearish, and the Dow Theory shows a mildly bearish position for both weekly and monthly time frames. The KST is bullish on a weekly basis but bearish monthly, and the RSI shows no signal for both time frames.\n\nIn terms of performance, LAVA has underperformed the S&P 500 over the past week and month, with returns of -4.55% and -3.29% respectively, while the S&P 500 gained 1.05% and 2.33%. However, year-to-date, LAVA has significantly outperformed the benchmark with a return of 54.57% compared to the S&P 500's 12.22%. Overall, the current technical stance is mildly bullish, but caution is warra..."
      },
      {
        "title": "Is LAVA Therapeutics NV overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lava-therapeutics-nv-overvalued-or-undervalued-3544092",
        "imagepath": "",
        "date": "2025-09-20 18:37:31",
        "description": "As of 17 May 2022, LAVA Therapeutics NV's valuation grade moved from does not qualify to risky, indicating a shift towards a more cautious assessment. The company appears to be overvalued given its current financial metrics, particularly with a Price to Book Value of 1.35 and an EV to EBIT of 0.90, which suggests that the market may be pricing in expectations that are not supported by its earnings performance. Additionally, the ROE is notably negative at -128.56%, further emphasizing the challenges the company faces.\n\nIn comparison to its peers, LAVA's valuation ratios are less favorable; for instance, Precision BioSciences, Inc. has a more favorable EV to EBITDA of -0.2328, while Marker Therapeutics, Inc. shows a better EV to EBIT at 0.0342. The stock has underperformed against the S&P 500 over the past year, returning -12.5% compared to the index's 17.14%, reinforcing the notion that LAVA may not be a com..."
      }
    ],
    "total": 6,
    "sid": "1287334",
    "stock_news_url": "https://www.marketsmojo.com/news/lava-therapeutics-nv-1287334"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is LAVA Therapeutics NV technically bullish or bearish?

2025-09-20 20:04:27

As of 24 July 2025, the technical trend for LAVA Therapeutics NV has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating positive momentum. The daily moving averages also reflect a mildly bullish stance. However, the monthly Bollinger Bands are bearish, and the Dow Theory shows a mildly bearish position for both weekly and monthly time frames. The KST is bullish on a weekly basis but bearish monthly, and the RSI shows no signal for both time frames. In terms of performance, LAVA has underperformed the S&P 500 over the past week and month, with returns of -4.55% and -3.29% respectively, while the S&P 500 gained 1.05% and 2.33%. However, year-to-date, LAVA has significantly outperformed the benchmark with a return of 54.57% compared to the S&P 500's 12.22%. Overall, the current technical stance is mildly bullish, but caution is warra...

Is LAVA Therapeutics NV overvalued or undervalued?

2025-09-20 18:37:31

As of 17 May 2022, LAVA Therapeutics NV's valuation grade moved from does not qualify to risky, indicating a shift towards a more cautious assessment. The company appears to be overvalued given its current financial metrics, particularly with a Price to Book Value of 1.35 and an EV to EBIT of 0.90, which suggests that the market may be pricing in expectations that are not supported by its earnings performance. Additionally, the ROE is notably negative at -128.56%, further emphasizing the challenges the company faces. In comparison to its peers, LAVA's valuation ratios are less favorable; for instance, Precision BioSciences, Inc. has a more favorable EV to EBITDA of -0.2328, while Marker Therapeutics, Inc. shows a better EV to EBIT at 0.0342. The stock has underperformed against the S&P 500 over the past year, returning -12.5% compared to the index's 17.14%, reinforcing the notion that LAVA may not be a com...

View All News